- Home
- APGE vs CROX Comparison
APGE vs CROX Comparison
Compare APGE & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APGE | CROX |
|---|---|---|
| Founded | 2022 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.5B |
| IPO Year | 2023 | 2005 |
Fundamental Metrics
Financial Performance| Metric | APGE | CROX |
|---|---|---|
| Price | $132.61 | $124.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 12 |
| Target Price | ★ $109.67 | $99.90 |
| AVG Volume (30 Days) | 1.2M | ★ 1.2M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.71 |
| Revenue | N/A | ★ $4,040,647,000.00 |
| Revenue This Year | N/A | $2.01 |
| Revenue Next Year | N/A | $2.60 |
| P/E Ratio | ★ N/A | $46.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $34.34 | $73.21 |
| 52 Week High | $95.32 | $129.79 |
Technical Indicators
Market Signals| Indicator | APGE | CROX |
|---|---|---|
| Relative Strength Index (RSI) | 81.67 | 62.28 |
| Support Level | $75.41 | $75.19 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.83 | 4.27 |
| MACD | 3.35 | -0.34 |
| Stochastic Oscillator | 99.30 | 62.92 |
Price Performance
Historical ComparisonAbout APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.